Global Metabolic Syndrome Market, By Diseases Type (Dysmetabolic Syndrome, Hypertriglyceridemia Waist, Insulin Resistance Syndrome, Obesity Syndrome, Syndrome X), By Diagnosis (Physical Exam, Blood Tests, Others), Treatment (Medication, lifestyle Changes, Others), Route of Administration (Oral, Parental, Others), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029.
Metabolic Syndrome Market Analysis and Size
The metabolic syndrome market is expected to witness significant growth during the forecast period. Growing cases of hypertension, cardiomyopathy, diabetes and hypercholesterolemia drives the metabolic syndrome market. Due to the adaptation of unhealthy lifestyle, increased stress in daily life & malnutrition and family history with cardiac disease also boost up the metabolic syndrome market growth. Many major market players are contributing a lot in drug discovery and development. COVID-19 also had a major impact on the market growth.
Data Bridge Market Research analyses a growth rate in the global metabolic syndrome market in the forecast period 2022-2029. The expected CAGR of global metabolic syndrome market is tend to be around 7.50% in the mentioned forecast period. The market was valued at USD 62 billion in 2021, and it would grow upto USD 110.58 billion by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
The condition known as metabolic syndrome is characterised by a number of disorders that coexist and raise the risk of heart disease, stroke, and type 2 diabetes. High blood sugar, abnormal cholesterol, elevated blood pressure, excess body fat around the waist, and elevated blood pressure are among these problems. Even though having one of the conditions does not necessarily guarantee that a patient has metabolic syndrome, having two to three diseases at once enhances the likelihood that they do. Increased urination and thirst are symptoms, along with weariness and hazy eyesight. It is crucial to the healthcare industry, therefore considerable growth is anticipated over the projection period.
Metabolic Syndrome Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Diseases Type (Dysmetabolic Syndrome, Hypertriglyceridemia Waist, Insulin Resistance Syndrome, Obesity Syndrome, Syndrome X), By Diagnosis (Physical Exam, Blood Tests, Others), Treatment (Medication, lifestyle Changes, Others), Route of Administration (Oral, Parental, Others), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Atkins Global (U.K.), Herbalife International of America Inc., (U.S.), Abbott (U.S.), Kellogg;s Co (U.S.), megalabs (U.S.), Johnson & Johnson Private Limited (U.S.), Medtronic (Ireland), Apollo Endosurgery Inc., (U.S.), GSK plc (U.K), Olympus Corporation (Japan), WW International Inc., (U.S.), Jenny Craig (U.S.), Gold’s Gym (U.S.), DSM (Netherlands), Brunswick Corporation (U.S.), Amer Sports (Finland), Johnson Health Tech (Taiwan), Technogym SpA (Italy), Shaklee Corporation (U.S.), Nature's Sunshine Products, Inc., (U.S.) and Novo Nordisk A/S (Denmark)
|
|
Market Opportunities
|
|
Global Metabolic Syndrome Market Dynamics
Drivers
- Rising Awareness For Disease Treatment
Rising awareness among patients and healthcare professionals for the treatment of different types of metabolic syndromes and more and more usage of combination therapy are the driving factors that is expected to boost the demand for global metabolic syndrome market during the forecast period of 2022-2029.
- Increased Clinical Studies and Government Initiatives
The global metabolic syndrome market is estimated to be driven by the rising R&D investments in drug discovery and development and the rising prevalence of diabetes. For instance, for the treatment of diabetes as a metabolic syndrome, as per the reports of International Diabetes Federation, around 415 million people are currently affected by diabetes globally and it is hoped to increase to 642 million diabetic people by the year 2040.
Opportunities
- Increasing Demand for Retail Pharmacies
Rise in the number of metabolic syndromes therapeutics being delivered through retail pharmacies and surge in the number of retail pharmacies in developed countries create opportunities for the market growth. In addition to this, patients prefer retail pharmacies for purchasing drugs, as these are easily accessible.
Restraints/Challenges
- Lack of Skilled Professionals
Lack of trained professionals who are unaware of the knowledge of the treatment methods for this disease could curb the growth of the global metabolic syndrome market over a forecast period.
- High Cost
The huge expenditure of the treatment methods surely hamper the market growth.
This global metabolic syndrome market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global metabolic syndrome market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Global Metabolic Syndrome Market
The Covid-19 pandemic negatively impacted the global metabolic syndrome market because the utmost priority was given to Covid-19 patients for treatment. Several medical colleges and hospitals were reorganised and helped in the structure so that they can accommodate more patients diagnosed with Covid-19. Discovery and development of drugs for the types of metabolic syndromes also slowed down during the pandemic, but surely it wasn’t in a pause and now in the post pandemic era, it is rising again.
Global Metabolic Syndrome Market Scope
The global metabolic syndrome market is segmented on the basis of disease type, diagnosis, treatment, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Disease Type
- Dysmetabolic Syndrome
- Hypertriglyceridemia Waist
- Insulin Resistance Syndrome
- Obesity Syndrome
- Syndrome X
Diagnosis
- Physical Exam
- Blood Tests
- Others
Treatment
- Medication
- Lifestyle Changes
- Others
Route of Administration
- Oral
- Parental
- Others
End-Users
- Hospitals
- Homecare
- Speciality Centres
- Others
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Metabolic Syndrome Market Regional Analysis/Insights
The global metabolic syndrome market is analysed and market size insights and trends are provided by disease type, diagnosis, treatment, route of administration, distribution channel and end-user as referenced above.
The major countries covered in the global metabolic syndrome market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America is expected to have the highest market growth due to increased geriatric population, and presence of key manufacture of the product.
Asia-Pacific dominates the market due to increased prevalence of coronary heart diseases and related disorders, increased awareness programmes on the healthy lifestyle and number of generic drugs
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Metabolic Syndrome Market Share Analysis
The global metabolic syndrome market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global metabolic syndrome market.
Key players operating in the global metabolic syndrome market include:
- Atkins Global (U.K.)
- Herbalife International of America Inc., (U.S.)
- Abbott (U.S.)
- Kellogg;s Co (U.S.)
- megalabs (U.S.)
- Johnson & Johnson Private Limited (U.S.)
- Medtronic (Ireland)
- Apollo Endosurgery Inc., (U.S.)
- GSK plc (U.K)
- Olympus Corporation (Japan)
- WW International Inc., (U.S.)
- Jenny Craig (U.S.)
- Gold’s Gym (U.S.)
- DSM (Netherlands)
- Brunswick Corporation (U.S.)
- Amer Sports (Finland)
- Johnson Health Tech (Taiwan)
- Technogym SpA (Italy)
- Shaklee Corporation (U.S.)
- Nature's Sunshine Products, Inc., (U.S.)
- Novo Nordisk A/S (Denmark)
SKU-